Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Breast J

Retrieve available abstracts of 82 articles:
HTML format
Text format



Single Articles


    October 2018
  1. MAZOUNI C, Koual M, De Leeuw F, Conversano A, et al
    Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Breast J. 2018 Oct 8. doi: 10.1111/tbj.13123.
    PubMed     Text format     Abstract available


  2. SURMELI ZG
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Oct 7. doi: 10.1111/tbj.13145.
    PubMed     Text format    


  3. CROCE MV, Cermignani L, Rabassa ME, Segal-Eiras A, et al
    Factors associated with breast cancer in an Argentine city.
    Breast J. 2018 Oct 4. doi: 10.1111/tbj.13147.
    PubMed     Text format    


    September 2018
  4. MESHKAT M, Baghestani AR, Zayeri F, Khayamzadeh M, et al
    Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.
    Breast J. 2018 Sep 30. doi: 10.1111/tbj.13120.
    PubMed     Text format     Abstract available


  5. HENNEGHAN A, Phillips C, Courtney A
    We are different: Young adult survivors' experience of breast cancer.
    Breast J. 2018 Sep 27. doi: 10.1111/tbj.13128.
    PubMed     Text format    


  6. CURREY A, Patten CR, Bergom C, Wilson JF, et al
    Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.
    Breast J. 2018 Sep 25. doi: 10.1111/tbj.13116.
    PubMed     Text format     Abstract available


  7. CRISPIN M, Udovicich C, Chan S, Wong S, et al
    Trends in genetic screening referral in breast cancer patients under the age of forty: 2001-2016.
    Breast J. 2018 Sep 24. doi: 10.1111/tbj.13130.
    PubMed     Text format    


  8. DOS SANTOS FIGUEIREDO FW, Schoueri JHM, Almeida TCDC, de Carvalho LEW, et al
    Risk factors for breast cancer mortality: Evidence from Brazil.
    Breast J. 2018 Sep 21. doi: 10.1111/tbj.13144.
    PubMed     Text format    


  9. WILSON PC, Chagpar AB, Cicek AF, Bossuyt V, et al
    Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score.
    Breast J. 2018 Sep 19. doi: 10.1111/tbj.13117.
    PubMed     Text format     Abstract available


  10. HOU Y, Nitta H, Wei L, Banks PM, et al
    PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer.
    Breast J. 2018 Sep 19. doi: 10.1111/tbj.13112.
    PubMed     Text format     Abstract available


  11. BRADLEY JA
    The current status of intraoperative radiation therapy in breast cancer: Challenges and promises.
    Breast J. 2018;24:713-714.
    PubMed     Text format    


    August 2018
  12. TAKUWA H, Hagiwara R, Takahara S, Yamauchi A, et al
    Assisted reproductive technology is effective for but does not affect the prognosis of young patients with breast cancer: Experience in a single institution.
    Breast J. 2018 Aug 16. doi: 10.1111/tbj.13083.
    PubMed     Text format     Abstract available


  13. YANG M, Barker K, Goodman D, Park HL, et al
    Effective risk communication to promote behavioral change in patients at elevated risk for breast cancer based on the Health Belief Model.
    Breast J. 2018 Aug 6. doi: 10.1111/tbj.13086.
    PubMed     Text format    


  14. POP CF, Stanciu-Pop C, Drisis S, Radermeker M, et al
    The impact of breast MRI workup on tumor size assessment and surgical planning in patients with early breast cancer.
    Breast J. 2018 Aug 3. doi: 10.1111/tbj.13104.
    PubMed     Text format     Abstract available


    July 2018
  15. PATEL S, Delikat A, Liao J, Chetlen AL, et al
    Pre- and post-magnetic resonance imaging features of suspicious internal mammary lymph nodes in breast cancer patients receiving neo-adjuvant therapy: Are any imaging features predictive of malignancy?
    Breast J. 2018 Jul 31. doi: 10.1111/tbj.13102.
    PubMed     Text format     Abstract available


  16. LOI M, Desideri I, Olmetto E, Francolini G, et al
    BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.
    Breast J. 2018 Jul 31. doi: 10.1111/tbj.13100.
    PubMed     Text format     Abstract available


  17. SOARES LR, Freitas-Junior R
    The impact of mammography screening on the surgical treatment of breast cancer.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13093.
    PubMed     Text format    


  18. HANNAN E, Peter O'Leary D, Cheung C, Buhamad F, et al
    Knowledge of breast cancer risk factors, screening, and treatment methods in patients attending the breast clinic: A survey of 1,018 women.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13082.
    PubMed     Text format    


  19. MANNU GS, Gammer B, Bettencourt-Silva JH, Tsoti SM, et al
    Prognostic factors for male breast cancer: A breast center's 10-year experience.
    Breast J. 2018 Jul 30. doi: 10.1111/tbj.13081.
    PubMed     Text format    


  20. TJALMA WAA
    When to perform a sentinel node biopsy in breast cancer patients undergoing neo-adjuvant chemotherapy?
    Breast J. 2018 Jul 26. doi: 10.1111/tbj.13088.
    PubMed     Text format    


  21. ALTUNDAG K
    Extent of metastases other than brain metastases may affect outcome in a breast cancer patients underwent resection of a brain metastases.
    Breast J. 2018 Jul 26. doi: 10.1111/tbj.13094.
    PubMed     Text format    


  22. VUGTS G, Van den Heuvel F, Maaskant-Braat AJG, Voogd AC, et al
    Predicting breast and axillary response after neoadjuvant treatment for breast cancer: The role of histology vs receptor status.
    Breast J. 2018 Jul 22. doi: 10.1111/tbj.13085.
    PubMed     Text format     Abstract available


  23. AZIM HA, Lasheen S, Kassem L
    Treatment of HER2-positive early breast cancer: How to best balance efficacy and toxicity?
    Breast J. 2018;24:459-461.
    PubMed     Text format    


    May 2018
  24. MELNOV S, Murphy P, Foley T, Nadyrov E, et al
    Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13056.
    PubMed     Text format    


  25. CAUGHRAN J, Braun TM, Breslin TM, Smith DR, et al
    The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13034.
    PubMed     Text format     Abstract available


  26. MANSOORI Y, Tabei MB, Askari A, Izadi P, et al
    Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13067.
    PubMed     Text format     Abstract available


  27. BALAGAMWALA EH, Manyam BV, Leyrer CM, Karthik N, et al
    Most patients are eligible for an alternative to conventional whole breast irradiation for early-stage breast cancer: A National Cancer Database Analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13051.
    PubMed     Text format     Abstract available


  28. MARIANI M, George K
    Neuropsychological and self-reporting outcomes following rehabilitation of cognitive dysfunction in survivors of breast cancer: A pilot study involving survivor-partner dyads.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13060.
    PubMed     Text format    


  29. BELAID I, Fatma LB, Ezzairi F, Hochlaf M, et al
    Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13062.
    PubMed     Text format    


  30. WHITE MC, Soman A, Weinberg CR, Rodriguez JL, et al
    Factors associated with breast MRI use among women with a family history of breast cancer.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13063.
    PubMed     Text format     Abstract available


  31. KODAGANUR S, Paga U, Ram A, Krishna A, et al
    Feasibility, safety, and clinical outcomes following latissimus dorsi flap reconstruction in breast cancer- an Institutional study.
    Breast J. 2018 May 8. doi: 10.1111/tbj.13059.
    PubMed     Text format    


    April 2018
  32. MURATA T, Jinno H, Takahashi M, Shimoda M, et al
    Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13033.
    PubMed     Text format     Abstract available


  33. LARSON KE, Grobmyer SR, Valente SA
    Evaluation of recurrence patterns and survival in modern series of young women with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13041.
    PubMed     Text format     Abstract available


  34. JIANG Z, Yang Y, Li S, Pan Z, et al
    A case of tonsillar metastasis from breast cancer and literature review.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13045.
    PubMed     Text format    


  35. KAIDAR-PERSON O, Marks LB, Jones EL
    Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13044.
    PubMed     Text format     Abstract available


  36. SCHNAPPER G, Marotti L, Casella D, Mano MP, et al
    Data managers: A survey of the European Society of Breast Cancer Specialists in certified multi-disciplinary breast centers.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13043.
    PubMed     Text format     Abstract available


    March 2018
  37. YOON HJ, Kim Y, Chung J, Kim BS, et al
    Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
    Breast J. 2018 Mar 30. doi: 10.1111/tbj.13032.
    PubMed     Text format     Abstract available


  38. KIM R, Kawai A, Wakisaka M, Funaoka Y, et al
    Outcomes of outpatient breast cancer surgery at a private breast clinic.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13012.
    PubMed     Text format     Abstract available


  39. KEIM-MALPASS J, Doede A, Camacho F, Kennedy C, et al
    Impact of patient health literacy on surgical treatment of breast cancer.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13011.
    PubMed     Text format     Abstract available


  40. CHO E, Wu Q, Rubinstein L, Linden H, et al
    Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
    Breast J. 2018 Mar 13. doi: 10.1111/tbj.13013.
    PubMed     Text format     Abstract available


  41. HANLEY BP, Walsh SM, O'Leary DP, MacNally SP, et al
    The significance of receptor status discordance between breast cancer primary and brain metastasis.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13028.
    PubMed     Text format    


  42. DIALANI V, Westra C, Venkataraman S, Fein-Zachary V, et al
    Indications for biopsy of imaging-detected intramammary and axillary lymph nodes in the absence of concurrent breast cancer.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13009.
    PubMed     Text format     Abstract available


  43. VIEIRA RADC, Silveira SFDS, Silva DRD, Tramonte MS, et al
    Knowledge and attitudes about breast cancer care in female inmates in Sao Paulo State/Brazil.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13025.
    PubMed     Text format    


  44. BARCO I, Fraile M, Vidal M, Cambra MJ, et al
    Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13014.
    PubMed     Text format    


  45. O'SHEA E, O'Reilly S, Smiddy P
    Rare imaging appearance of skeletal metastases in a 61-year-old breast cancer patient.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13019.
    PubMed     Text format    


  46. CLIFTON K, Barnett C, Martinez A, Karuturi M, et al
    Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13026.
    PubMed     Text format    


  47. KAMAL M, Nafie EHO, Elsers S, Alanwar S, et al
    Ethnicity influences breast cancer stem cells' drug resistance.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13021.
    PubMed     Text format    


  48. VOHRA NA, Brinkley J, Kachare S, Muzaffar M, et al
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13005.
    PubMed     Text format     Abstract available


  49. TOZBIKIAN GH, Zynger DL
    HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13004.
    PubMed     Text format     Abstract available


  50. SMITH IORFIDO SM, Makariou E
    Empyema necessitans mimicking inflammatory breast cancer-An unusual case of breast edema.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13015.
    PubMed     Text format    


  51. YADAV S, Jinna S, Pereira-Rodrigues O, Reeves A, et al
    Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13007.
    PubMed     Text format     Abstract available


  52. UNKART JT, Proudfoot J, Wallace AM
    Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13002.
    PubMed     Text format     Abstract available


    February 2018
  53. NOWIKIEWICZ T, Zegarski W, Pagacz K, Nowacki M, et al
    Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Breast J. 2018 Feb 24. doi: 10.1111/tbj.12997.
    PubMed     Text format     Abstract available


  54. CAMPBELL A, Heydarian R, Ochoa C, Dwivedi AK, et al
    Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Breast J. 2018 Feb 14. doi: 10.1111/tbj.12951.
    PubMed     Text format     Abstract available


  55. SWINTELSKI C, Plaza M
    Successful cryoablation of breast cancer.
    Breast J. 2018 Feb 7. doi: 10.1111/tbj.12996.
    PubMed     Text format     Abstract available


    January 2018
  56. WEINER A, D'Andrea GM
    Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12972.
    PubMed     Text format     Abstract available


  57. BARROU J, Tallet A, Cohen M, Bannier M, et al
    Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12993.
    PubMed     Text format     Abstract available


  58. COOPEY SB, Acar A, Griffin M, Cintolo-Gonzalez J, et al
    The impact of patient age on breast cancer risk prediction models.
    Breast J. 2018 Jan 8. doi: 10.1111/tbj.12976.
    PubMed     Text format     Abstract available


    December 2017
  59. DECOSTER L, Fontaine C, Vanacker L, Schallier D, et al
    Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12990.
    PubMed     Text format    


  60. GARG M, Prabhakar N, Singla V, Singh T, et al
    Breast cancer in a patient with neurofibromatosis type 1.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12987.
    PubMed     Text format    


  61. FONSECA V, Brito M
    Starting hormone therapy immediately after histological diagnosis of breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12995.
    PubMed     Text format    


  62. MERCKEL LG, Verburg E, van der Velden BHM, Loo CE, et al
    Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12984.
    PubMed     Text format     Abstract available


  63. MARTIN-ROMANO P, Baraibar I, Espinos J, Legaspi J, et al
    Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12975.
    PubMed     Text format     Abstract available


  64. HWANG E, Yap ML, Boxer MM, Chong S, et al
    Variations in breast cancer histology and treatment patterns between the major ethnic groups of South West Sydney.
    Breast J. 2017 Dec 19. doi: 10.1111/tbj.12973.
    PubMed     Text format     Abstract available


  65. PASRICHA S, Gupta G, Garg R, Sharma A, et al
    Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12981.
    PubMed     Text format     Abstract available


  66. KAIDAR-PERSON O, Deal AM, Anders CK, Ewend MG, et al
    The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12919.
    PubMed     Text format    


  67. KUMAR RV, Bhasker S
    A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12965.
    PubMed     Text format    


  68. BAYO J, Avino V, Toscano F, Jimenez F, et al
    Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo-adjuvant treatment for Her2 positive breast cancer patients and impact of colony-stimulating factor prophylaxis.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12927.
    PubMed     Text format     Abstract available


    November 2017
  69. LI T, Tang L, Gandomkar Z, Heard R, et al
    Mammographic density and other risk factors for breast cancer among women in China.
    Breast J. 2017 Nov 29. doi: 10.1111/tbj.12967.
    PubMed     Text format    


  70. WEINBERG MS, Shachar SS, Muss HB, Deal AM, et al
    Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12952.
    PubMed     Text format     Abstract available


  71. PASSHAK M, Shachar SS, Bar-Sela G, Fried G, et al
    Breast cancer in young women aged 35 and under: Patterns of care and outcome.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12966.
    PubMed     Text format    


  72. HLUBOCKY J, Bhavnagri S, Swinford A, Mitri C, et al
    Does the use of pretreatment MRI change the management of patients with newly diagnosed breast cancer?
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12946.
    PubMed     Text format     Abstract available


  73. SALERNO C, Vento AR, Giacchino M, Lissidini G, et al
    Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report.
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12944.
    PubMed     Text format     Abstract available


  74. SHAGISULTANOVA E, Mayordomo J, Elias AD
    Triple-negative breast cancer in the elderly.
    Breast J. 2017;23:627-629.
    PubMed     Text format    


    October 2017
  75. WHITWORTH PW, Cooper A
    Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12939.
    PubMed     Text format     Abstract available


  76. MERRILL RM
    Conditional relative survival among female breast cancer patients in the United States.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12933.
    PubMed     Text format    


  77. OBA T, Ono M, Iesato A, Hanamura T, et al
    Chylous leakage after axillary lymph node dissection in a patient with breast cancer.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12934.
    PubMed     Text format    


  78. KHOURY A, Parihar V, O'steen L, Cherabuddi K, et al
    Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer.
    Breast J. 2017 Oct 13. doi: 10.1111/tbj.12943.
    PubMed     Text format     Abstract available


    September 2017
  79. BIGNON L, Fricker JP, Nogues C, Mouret-Fourme E, et al
    Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
    Breast J. 2017 Sep 19. doi: 10.1111/tbj.12887.
    PubMed     Text format     Abstract available


  80. OTA K, Rivera C, Martin M
    Specimen mammography distorts margin status in patients undergoing breast conserving surgery for early-stage breast cancer.
    Breast J. 2017 Sep 15. doi: 10.1111/tbj.12920.
    PubMed     Text format    


  81. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized pemphigus vulgaris after breast cancer radiotherapy.
    Breast J. 2017 Sep 11. doi: 10.1111/tbj.12910.
    PubMed     Text format     Abstract available


  82. LEE AY, Joe BN, Price ER
    The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?
    Breast J. 2017;23:501-503.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: